Selling sickness: the pharmaceutical industry and disease mongering.
BMJ. 2002 Apr 13;324(7342):886-91.
Comment in:
- BMJ. 2002 Jul 27;325(7357):216; author reply 216.
- BMJ. 2002 Jul 27;325(7357):216; author reply 216.
- BMJ. 2002 Jul 27;325(7357):216; author reply 216.
- BMJ. 2002 Jul 27;325(7357):216; author reply 216.
- BMJ. 2002 Jul 27;325(7357):216; author reply 216.
- BMJ. 2002 Jul 27;325(7357):216; author reply 216.
- BMJ. 2002 Jul 27;325(7357):216; author reply 216.
- BMJ. 2002 Jul 27;325(7357):216; author reply 216.
Moynihan R, Heath I, Henry D.
Australian Financial Review, GPO Box 506, Sydney, 2201, Australia. ray_128@hotmail.com11950740 [PubMed - indexed for MEDLINE]
Related Articles:- Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
- A 66-year-old man with sexual dysfunction.
- Re: Variations of the internal pudendal artery as a congenital contributing factor to age at onset of erectile dysfunction in Japanese.
- Ejaculatory dysfunction and alpha-adrenoceptor antagonists.
- 5-HT1A receptors on oxytocin neurons and premature ejaculation–a comment.























0 comments
Kick things off by filling out the form below.
Leave a Comment